0001193125-26-102178
SEC filingRelay Therapeutics, Inc. amended its bylaws, with the Board of Directors approving the Second Amended and Restated Bylaws on March 6, 2026. The filing includes Exhibit 3.1 containing the bylaws and was submitted on March 11, 2026.